Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
DAK — Predicate Candidate Screening
28 FDA 510(k) clearances under this product code; the 50 most recent screened below.
55 daysmedian FDA review time
275 days90th percentile
28clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K031563 | BINDAZYME CLQ CIC EIA KIT | The Binding Site, Ltd. | 2003-09-10 | 114 | 1 |
| K032254 | IBL C1Q-CIC CIA TEST | Ibl GmbH | 2003-08-29 | 38 | 0 |
| K012576 | CIC-C1Q EIA | American Laboratory Products Co., Ltd. | 2002-01-29 | 173 | 0 |
| K973203 | THYMOSTAT ELISA FOR THE DETECTION OF HUMAN IGG,M AND A ANTI- | Sangstat Medical Corp. | 1998-09-30 | 400 | 0 |
| K972873 | IMMUSTRIP HAMA IGG | Immunomedics, Inc. | 1998-03-17 | 225 | 0 |
| K951968 | HUMAN C1Q RADIAL IMMUNODIFFUSION KIT | Kent Laboratories, Inc. | 1995-05-30 | 33 | 0 |
| K914388 | C1 RID KIT | The Binding Site, Ltd. | 1991-10-28 | 27 | 0 |
| K882829 | CIRCULATING IMMUNE COMPLEXES CONTROLS | Cytotech, Inc. | 1988-08-04 | 27 | 0 |
| K860996 | SANASSAY IC TEST | Scientific Sales Intl., Inc. | 1987-03-30 | 384 | 0 |
| K864312 | IC MICROASSAY | Diamedix Corp. | 1987-01-09 | 67 | 0 |
| K862649 | CYTOTECH CIC ENZYME IMMUNOASSAY | Cytotech, Inc. | 1986-09-04 | 55 | 0 |
| K861499 | BIOSTAR* READS* IMMUNE COMPLEX ASSAY KIT | Biostar Medical Products, Inc. | 1986-06-20 | 58 | 0 |
| K853697 | BIOSTAR RE-A-DS IMMUNE COMPLEX ASSAY KIT | Biostar Medical Products, Inc. | 1985-12-16 | 103 | 0 |
| K851202 | GILFORD TRI-LEVEL ASSAYED IMMUNOLOGY CONTROL | Gilford | 1985-04-29 | 34 | 0 |
| K844294 | CORDIA IC | Cordis Corp. | 1985-02-04 | 90 | 0 |
| K833275 | GMP CIQ ELISA TEST KIT | Gamma Medical Products, Inc. | 1984-06-22 | 275 | 0 |
| K833636 | ORTHO* SERUM ELISA TEST SYSTEM | Ortho Diagnostic Systems, Inc. | 1984-06-13 | 240 | 0 |
| K841541 | SERUM COMPLEMENT ACTIVITY TEST-SCAT | Collaborative Research, Inc. | 1984-06-01 | 46 | 0 |
| K823009 | GAMMA CLQ | Gamma Medical Products, Inc. | 1982-11-05 | 24 | 0 |
| K821949 | ORTHO* ALTERNATIVE PATHWAY COMPL. TEST | Ortho Diagnostic Systems, Inc. | 1982-08-27 | 58 | 0 |
| K821806 | ORTHO CLG IMMUNE COMPLEX TEST SYSTEM | Ortho Diagnostic Systems, Inc. | 1982-06-25 | 8 | 0 |
| K792472 | ELECTRO-IMMUNO-QUANTITATION (EIQ) | Icl Scientific | 1979-12-27 | 24 | 0 |
| K781022 | ANTI-HUMAN CIQ SERUM | Icl Scientific | 1978-08-14 | 56 | 0 |
| K780729 | LAS-R HUMAN COMPLEMENT CLQ TEST | Hyland Therapeutic Div., Travenol Laboratories | 1978-05-18 | 16 | 0 |
| K772114 | FIAX C4 ASSAY | Idt, A Division of Whittaker M.A. Bioproducts | 1977-11-30 | 23 | 0 |
| K772003 | HUMAN REFERENCE SERUM C4 COMPLEMENT | G.D. Searle and Co. | 1977-11-03 | 13 | 0 |
| K770964 | GOAT ANTISERUM COMPLEMENT C3 NEPHEL. | Kallestad Laboratories, Inc. | 1977-06-24 | 28 | 0 |
| K770547 | LAS-R TM HUMAN COMPLEMENT C4 TEST | Hyland Therapeutic Div., Travenol Laboratories | 1977-05-03 | 43 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda